JVJitka Vaculová

Jitka Vaculová

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jitka Vaculová has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Non-invasive approaches for esophageal microbiota analysis: a pilot study

    by J. Vaculova, R. Kroupa, J. Lochman, Z. Kala, P. Borilova Linhartova, M. Zapletalova, T. Deissova, L. Kunovsky

    Aims There is growing evidence that alterations in the composition of esophageal microbiota occur in gastroesophageal reflux disease (GERD). Recently non-invasive esophageal swabs have been introduced collecting a representative sample of the microbiota along the entire length of the esophagus [1]. Methods We aimed to profile the bacteriome of the esophagus and oral swabs in patients with symptoms of GERD. The collection of oral microbiota and esophageal microbiota by a minimally invasive tool EsophaCap was performed in 12 patients, who were followed up for GERD. The bacteriome was analyzed by sequencing the V1-V2 region of the 16S rRNA gene on the Illumina MiniSeq platform enabling classification up to the species level. Results The analysis of the most abundant phyla in both analyzed samples (oral swabs and EsophaCap) corresponded to the typical bacteria composition of the upper GIT. Although the most abundant taxa overlapped between both sampling methods, the oral swabs did not cluster distinctly from EsophaCap samples. The samples collected by EsophaCap showed higher alpha diversity and the proportional abundances between both collection methods differed significantly. Besides, we observed statistically significant differences in the representation of the diagnostically important bacterial genera such as Prevotella (p<0.001) or Veillonella (p<0.001) that showed higher representation in EsophaCap samples compared to oral samples. Conclusions The results of our pilot study suggest that EsophaCap, reflects more appropriately the bacterial structure of the upper GIT compared to oral swabs. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    The Use of Confocal Laser Endomicroscopy in Diagnosing Barrett’s Esophagus and Esophageal Adenocarcinoma

    by Jitka Vaculová, Radek Kroupa, Zdeněk Kala, Jiří Dolina, Tomáš Grolich, Jakub Vlažný, David Said, Lydie Izakovičová Hollá, Petra Bořilová Linhartová, Vladimír Procházka, et al.

    Confocal laser endomicroscopy (CLE) is a diagnostic technique that enables real-time microscopic imaging during microscopic examination and evaluation of epithelial structures with 1000-fold magnification. CLE can be used in the diagnosis of various pathologies, in pneumology, and in urology, and it is very widely utilized in gastroenterology, most importantly in the diagnosis of Barrett’s esophagus (BE), esophageal adenocarcinoma (EAC), biliary strictures, and cystic pancreatic lesions. A literature search was made in MEDLINE/PubMed and Google Scholar databases while focusing on diagnostics using CLE of BE and EAC. We then examined randomized and observational studies, systematic reviews, and meta-analyses relating to the utilization of CLE in BE and EAC diagnostics. Here, we discuss whether CLE can be a suitable diagnostic method for surveillance of BE. Even though many studies have proven that CLE increases diagnostic accuracy in detecting neoplastic transformation of BE, CLE is still not used as a standard diagnostic tool in BE surveillance due to a deficiency of scientific evidence. More studies and data are needed if CLE is to find a place as a new technique in BE surveillance.


  • Open Access

    Autoimmune Diseases of Digestive Organs—A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation

    by Lumir Kunovsky, Petr Dite, Petr Jabandziev, Zdenek Kala, Jitka Vaculova, Tomas Andrasina, Matej Hrunka, Martina Bojkova, Jan Trna

    It is well known that some pathological conditions, especially of autoimmune etiology, are associated with the HLA (human leukocyte antigen) phenotype. Among these diseases, we include celiac disease, inflammatory bowel disease, autoimmune enteropathy, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis. Immunoglobulin G4-related diseases (IgG4-related diseases) constitute a second group of autoimmune gastrointestinal, hepatobiliary and pancreatic illnesses. IgG4-related diseases are systemic and rare autoimmune illnesses. They often are connected with chronic inflammation and fibrotic reaction that can occur in any organ of the body. The most typical feature of these diseases is a mononuclear infiltrate with IgG4-positive plasma cells and self-sustaining inflammatory response. In this review, we focus especially upon the hepatopancreatobiliary system, autoimmune pancreatitis and IgG4-related sclerosing cholangitis. The cooperation of the gastroenterologist, radiologist, surgeon and histopathologist is crucial for establishing correct diagnoses and appropriate treatment, especially in IgG4 hepatopancreatobiliary diseases.


  • Open Access

    Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis

    by Lumír Kunovský, Petr Dítě, Petr Jabandžiev, Michal Eid, Karolina Poredská, Jitka Vaculová, Dana Sochorová, Pavel Janeček, Pavla Tesaříková, Martin Blaho, et al.

    Exocrine pancreatic insufficiency (EPI), an important cause of maldigestion and malnutrition, results from primary pancreatic disease or is secondary to impaired exocrine pancreatic function. Although chronic pancreatitis is the most common cause of EPI, several additional causes exist. These include pancreatic tumors, pancreatic resection procedures, and cystic fibrosis. Other diseases and conditions, such as diabetes mellitus, celiac disease, inflammatory bowel disease, and advanced patient age, have also been shown to be associated with EPI, but the exact etiology of EPI has not been clearly elucidated in these cases. The causes of EPI can be divided into loss of pancreatic parenchyma, inhibition or inactivation of pancreatic secretion, and postcibal pancreatic asynchrony. Pancreatic enzyme replacement therapy (PERT) is indicated for the conditions described above presenting with clinically clear steatorrhea, weight loss, or symptoms related to maldigestion and malabsorption. This review summarizes the current literature concerning those etiologies of EPI less common than chronic pancreatitis, the pathophysiology of the mechanisms of EPI associated with each diagnosis, and treatment recommendations.